Assessing whether one has a genetic predisposition to developing autoimmune diseases allows for the implementation of dietary and supplement strategies with a preventive approach.
Assessing whether one has a genetic predisposition to type 2 diabetes allows for the implementation of dietary and supplement strategies with a preventive focus.
Assessing whether one has a genetic predisposition to fatty liver disease allows for the implementation of dietary and supplement strategies with a preventive focus.
Assessing whether you have a genetic predisposition to obesity allows you to implement dietary and integrative strategies from a preventive perspective.
The protein BAFF (B cell Activating Factor) has been known to the scientific community for well over a decade, and numerous studies have elucidated its involvement in various processes as well as its potential relationships with inflammation, including inflammation related to diet.
For a long time, ESR and CRP have been the primary biomarkers for assessing inflammation. However, these "acute-phase" proteins have limitations in specificity and sensitivity for identifying low-grade inflammation. Other biomarkers, such as BAFF and PAF, which are linked to specific immune pathways, are more accurate for this type of inflammation.